Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.

PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...

Life's essential functions are powered by a set of compounds called metabolites, which are involved in every natural process, ...

Also known as type 1.5 diabetes, here’s what to know about the onset, symptoms, diagnosis, and treatment options for latent ...

A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...

Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

A recent study released by researchers from Pohang University of Science and Technology (POSTECH) opens the door for more effective diabetes research and treatment. The new approach leverages ...

A new study from the University of Michigan offers hope for a better way to care for DKA patients — one that could keep many ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Researchers at King’s College London have developed a powerful new AI model that can predict a person’s risk of ...